Nanjing TransThera Biosciences Co.
Latest round
- Series D
Last raised
- Feb 2023
Total raised
- $258M
Investors
- 24
About Nanjing TransThera Biosciences Co.
Based in Nanjing, China, and founded in 2016, Nanjing TransThera Biosciences Co. Ltd. specializes in the treatment of oncology, cardiovascular, and inflammatory diseases. The company was founded by Frank Wu. In July 2021, Nanjing TransThera Biosciences Co. Ltd. In 2020, the company has cooperated with Teijin Polycarbonate. Nanjing TransThera Biosciences Co. Ltd. is a biotechnology company specializing in developing therapeutics for diseases that need major treatment, like oncology, cardiovascular, and inflammatory diseases. The company's advanced pipeline product, IT-00420, is a clinical-stage spectrum-selective kinase inhibitor that exerts anti-tumor effects by targeting tumor cells and improving the tumor microenvironment. The company's other products include IT-00434 for gastrointestinal tumors, IT-01688 for IBD, TT-00920 for heart failure, and TT-01025 for non-alcoholic steatohepatitis (NASH). The company plans to provide better options for GI cancer patients through collaboration with Roche in the future.
Who invested in Nanjing TransThera Biosciences Co.
24 investors across 6 rounds
See all investors in Nanjing TransThera Biosciences Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nanjing TransThera Biosciences Co.
Who invested in Nanjing TransThera Biosciences Co.?
Nanjing TransThera Biosciences Co. has 24 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanjing TransThera Biosciences Co. raised?
Nanjing TransThera Biosciences Co. has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Nanjing TransThera Biosciences Co. last raise money?
Nanjing TransThera Biosciences Co.'s most recent round on record is a Series D, in Feb 2023.
What does Nanjing TransThera Biosciences Co. do?
Based in Nanjing, China, and founded in 2016, Nanjing TransThera Biosciences Co.
Where is Nanjing TransThera Biosciences Co. headquartered?
Nanjing TransThera Biosciences Co. is headquartered in Nanjing, China.
Which VCs invest in companies like Nanjing TransThera Biosciences Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Nanjing TransThera Biosciences Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Nanjing TransThera Biosciences Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.